IVD Raw Materials
RNA development programs face mounting pressure to compress timelines while maintaining consistent quality and delivery readiness.
04-14-2026 Shambhavi Shubham Ph.D., Senior Manager of R&D, Genscript USA Inc.
02-05-2026 Juliana Campo Garcia, Field Application Scientist, GenScript
The AmMag™ Quatro Automated System Series - including the Maxi 1400, Mini 1100, and ProAb 1300 - combined with a wide range of compatible AmMag™ magnetic beads, offers a fully automated solution from mini to maxi scale. This platform delivers high yield,
11-06-2025 Kamil Sekulski, Ph.D. Field Application Scientist
In this webinar, we’ll introduce technical solutions and application cases for small RNA drug conjugation, focusing on conjugate product identification, precise delivery and gene silencing, and differences across methods
10-28-2025 Jacob Guo Ph.D. , Director, Nucleic Acid Platform R&D Department, GenScript
Glioblastoma (GBM) is an aggressive brain tumor with a five-year survival rate of only 5.5%. The highly suppressive tumor microenvironment (TME) presents a major barrier to CAR-T efficacy- but a revolutionary mix of multiplex editing and machine learning
10-22-2025 Xia Sheng, Ph.D, Director of Bio-Bigdata Platform, GenScript / Scott Pritchett, Sr. Global Market Development Manager, GenScript
In this webinar, we’ll introduce how GenScript’s Cytosinct™ Cell Isolation Nanobeads Customization Service and Enceed™ T Cell Activation Reagent empower researchers and developers to achieve optimal performance across diverse therapeutic workflows.
10-15-2025 Vevian Zhang, Sr. Product Manager